Inhibition of staphylococcus aureus biofilms by a novel antibacterial envelope for use with implantable cardiac devices

Clinical and Translational Science

Volumn 2, Issue 3, 2009, Pages 193-198

  Agostinho, Alessandra ^a   James, Garth ^a   Wazni, Oussama ^b   Citron, Mark ^c   Wilkoff, Bruce D ^b  

^a MONTANA STATE UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c TyRxPharrna Inc   (United States)

Author keywords

Antibacterial envelopes; Biofilms; Cardiac device infection; Cardiovascular implantable electronic device; CDI; CIEDs; Staphylo cocci

Indexed keywords

MINOCYCLINE; POLYPROPYLENE; RIFAMPICIN; TITANIUM;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL COUNT; BIOFILM; BIOFILM REACTOR; CARDIOVASCULAR EQUIPMENT; CARDIOVASCULAR IMPLANTABLE ELECTRONIC DEVICE; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ELUTION; IN VITRO STUDY; MATERIAL COATING; NONHUMAN; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; BIOFILMS; COLONY COUNT, MICROBIAL; HEART VALVE PROSTHESIS; HUMANS; PROSTHESIS-RELATED INFECTIONS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

BACTERIA (MICROORGANISMS); STAPHYLOCOCCUS AUREUS;

EID: 77953458711     PISSN: 17528054     EISSN: 17528062     Source Type: Journal    
DOI: 10.1111/j.1752-8062.2009.00123.x     Document Type: Article

References (34)

1. Wilkoff BL, Auricchio A, Brugada J, Cowie M, Ellenbogen KA, Gillis AM, Hayes DL, Hewlett JG, Kautzner J, Love A, Morgan JM, Priori SG, Reynolds DW, Schoenfeld MH, Vardas PE. HRS/EHRA expert consensus on the monitoring of cardiovascular implantable electronic devices (CIEDs) description of techniques, indications, personnel, frequency and ethical considerations. Heart Rhythm. 2008; 5(6): 907-925.
2. Chua JD, Wilkoff BL, Lee I, Juratli N, Longworth DL, Gordon SM. Diagnosis and management of infections involving implantable electrophysiologic cardiac devices. Ann Intern Med 2000; 133(8): 604-608.
3. Hedrick TL, Adams JD, Sawyer RG. Implant-associated infections: An overview. J Long Term Eft Med Implants. 2006; 16(1): 83-99.
4. Klug D, Balde M, Pavin D, Hidden-Lucet F, Clementy J, Sadoul N, Rey JL, Lande G, Lazarus A, Victor J, Barnay C, Grandbastien B, Kacet S. Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: Results of a large prospective study. Circulation. 2007; 116(12): 1349-1355.
5. Karchmer AW, Longworth DL. Infections of intracardiac devices. Infect Dis Clin North Am. 2002; 16(2): 477-505, xii.
6. Cabell CH, Heidenreich PA, Chu VH, Moore CM, Stryjewski ME, Corey GR, Fowler VG, Jr. Increasing rates of cardiac device infections among Medicare beneficiaries: 1990-1999. Am Heart J. 2004; 147(4): 582-586.
7. Uslan DZ, Baddour LM. Cardiac device infections: Getting to the heart of the matter. Curr Opin infect Dis. 2006; 19(4): 345-348.
8. Harcombe AA, Newell SA, Ludman PR, Wistow TE, Sharpies LD, Schofield PM, Stone DL, Shapiro LM, Cole T, Petch MC. Late complications following permanent pacemaker implantation or elective unit replacement. Heart. 1998; 80(3): 240-244.
9. Rundstrom H, Kennergren C, Andersson R, Alestig K, Hogevik H. Pacemaker endocarditis during 18 years in Goteborg. Scand J Infect Dis 2004; 36(9): 674-679.
10. Giamarellou H. Nosocomial cardiac infections. J Hosp Infect. 2002; 50(2): 91-105.
11. Wilkoff BL. How to treat and identify device infections. Heart Rhythm. 2007; 4(11): 1467-1470.
12. Sohail MR, Uslan DZ, Khan AH, Friedman PA, Hayes DL, Wilson WR, Steckelberg JM, Stoner S, Baddour LM. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. J Am Coll Cardiol. 2007; 49(18): 1851-1859.
13. Rubin RJ, Harrington CA, Poon A, Dietrich K, Greene JA, Moiduddin A. The economic impact of Staphylococcus aureus infection in New York City hospitals. Emerg Infect Dis. 1999; 5(1) 9-17.
14. Darouiche RO. Treatment of infections associated with surgical implants. N Engl J Med. 2004; 350(14): 1422-1429.
15. Klug D, Wallet F, Lacroix D, Marquie C, Kouakam C, Kacet S, Courcol R. Local symptoms at the site of pacemaker implantation indicate latent systemic infection. Heart. 2004; 90(8): 882-886.
16. Pichlmaier M, Marwitz V, Kühn C, Niehaus M, Klein G, Bara C, Haverich A, Abraham WR. High prevalence of asymptomatic bacterial colonization of rhythm management devices. Europace 2008; 10: 1067-1072.
17. Borek PP, Wilkoff BL. Pacemaker and ICD leads: Strategies for long-term management. J Interv Card Electrophysiol. 2008; 23(1): 59-72.
18. Da Costa A, Kirkorian G, Cucherat M, Delahaye F, Chevalier P, Cerisier A, Isaaz K, Touboul P. Antibiotic prophylaxis for permanent pacemaker implantation: A meta-analysis. Circulation. 1998; 97(18): 1796-1801.
19. Furuya EY, Lowy FD. Antimicrobial strategies for the prevention and treatment of cardiovascular infections. Curr Opin Pharmacol. 2003; 3(5): 464-469.
20. Darouiche RO, Mansouri MD, Raad I, I. Efficacy of antimicrobial-impregnated silicone sections from penile implants in preventing device colonization in an animal model. Urology. 2002; 59(2) 303-307.
21. Darouiche RO, Raad, II, Heard SO, Thornby Jl, Wenker OC, Gabrielli A, Berg J, Khardori N, Hanna H, Hachem R, Harris RL, Mayhall G. A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group. N Engl J Med. 1999; 340(1): 1-8.
22. Donlan RM, Piede JA, Heyes CD, Sanii L, Murga R, Edmonds P, El-Sayed I, El-Sayed MA. Model system for growing and quantifying Streptococcus pneumoniae biofilms in situ and in real time. Appl Environ Microbiol. 2004; 70(8): 4980-4988.
23. Rao PV. Statistical Research Methods in the Life Sciences. Pacific Grove, CA: Duxbuiy Press, 1998.
24. Arber N, Pras E, Copperman Y, Schapiro JM, Meiner V, Lossos IS, Militianu A, Hassin D, Shai A. Pacemaker endocarditis. Report of 44 cases and review of the literature. Medicine (Baltimore). 1994; 73(6): 299-305.
25. Klug D, Lacroix D, Savoye C, Goullard L, Grandmougin D, Hennequin JL, Kacet S, Lekieffre J. Systemic infection related to endocarditis on pacemaker leads: Clinical presentation and management. Circulation. 1997; 95(8): 2098-2107.
26. Wolcott RD, Ehrlich GD. Biofilms and chronic infections. JAMA 2008; 299(22): 2682-2684.
27. Karchmer AW, Longworth DL. Infections of intracardiac devices. Cardiol Clin. 2003; 21(2) 253-271, vii.
28. Chang S, Sievert DM, Hageman JC, Boulton ML, Tenover FC, Downes FP, Shah S, Rudrik JT, Pupp GR, Brown WJ, Cardo D, Fridkin SK. Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med. 2003; 348(14): 1342-1347.
29. Gotz F. Staphylococcus and biofilms. MolMicrobiol. 2002; 43(6): 1367-1378.
30. Dy Chua J, Abdul-Karim A, Mawhorter S, Procop GW, Tchou P, Niebauer M, Saliba W, Schweikert R, Wilkoff BL. The role of swab and tissue culture in the diagnosis of implantable cardiac device infection. Pacing Clin Electrophysiol. 2005; 28(12): 1276-1281.
31. Carson CC, III. Efficacy of antibiotic impregnation of inflatable penile prostheses in decreasing infection in original implants. J Urol. 2004; 171(4): 1611-1614.
32. Darouiche RO, Meade R, Mansouri MD, Netscher DT. In vivo efficacy of antimicrobe-impregnated saline-filled silicone implants. Plast Reconstr Surg. 2002; 109(4): 1352-1357.
33. Hansen L, Brown M, Johnson D, Palme D, Love C, Darouiche R. A novel in vivo model of human pathogen infection and demonstration of efficacy by an antimicrobial pouch for pacing devices. Pacing Clin Electrophysiol. In press, 2009.
34. U.S. Department of Health and Human Services. U.S. Food and Drug Administration. Available at: http://www.accessdata.fda.gov/scripts/cdrh/ cfdocs/cfPMN/pmn.cfm?ID=23059. Accessed August 19,2008.